Glial cell line-derived neurotrophic factor enhances in vitro differentiation of mid-/hindbrain neural progenitor cells to dopaminergic-like neurons

Journal of Neuroscience Research

Volumn 88, Issue 15, 2010, Pages 3222-3232

  Young, Amber ^a   Assey, Kristin S ^b   Sturkie, Carla D ^b   West, Franklin D ^b   Machacek, David W ^c   Stice, Steven L ^a,b,c  

^a Biomedical Health Sciences Institute   (United States)

^b Animal and Dairy Science   (United States)

^c Aruna Biomedical   (United States)

Author keywords

Dopaminergic development; Human embryonic stem cells; Neural progenitor cells; Parkinson's disease

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ARTICLE; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; IMMUNOCYTOCHEMISTRY; MOUSE; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHOMBENCEPHALON;

BRAIN; CELL DIFFERENTIATION; CELL LINE; CELL SEPARATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; EMBRYONIC STEM CELLS; FLOW CYTOMETRY; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, CONFOCAL; NEURONS; POLYMERASE CHAIN REACTION;

EID: 78649430305     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22499     Document Type: Article

References (55)

1. Airaksinen MS, Saarma M. 2002. The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 3:383-394.
2. Akerud P, Alberch J, Eketjall S, Wagner J, Arenas E. 1999. Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons. J Neurochem 73:70-78.
3. Anwar MR, Andreasen CM, Lippert SK, Zimmer J, Martinez-Serrano A, Meyer M. 2008. Dopaminergic differentiation of human neural stem cells mediated by cocultured rat striatal brain slices. J Neurochem 105:460-470.
4. Arenas E, Trupp M, Akerud P, Ibanez CF. 1995. GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron 15:1465-1473.
5. Beck KD, Valverde J, Alexi T, Poulsen K, Moffat B, Vandlen RA, Rosenthal A, Hefti F. 1995. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373:339-341.
6. Bowenkamp KE, Hoffman AF, Gerhardt GA, Henry MA, Biddle PT, Hoffer BJ, Granholm AC. 1995. Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J Comp Neurol 355:479-489.
7. Buj-Bello A, Buchman VL, Horton A, Rosenthal A, Davies AM. 1995. GDNF is an age-specific survival factor for sensory and autonomic neurons. Neuron 15:821-828.
8. Buytaert-Hoefen KA, Alvarez E, Freed CR. 2004. Generation of tyrosine hydroxylase positive neurons from human embryonic stem cells after coculture with cellular substrates and exposure to GDNF. Stem Cells 22:669-674.
9. Cacalano G, Farinas I, Wang LC, Hagler K, Forgie A, Moore M, Armanini M, Phillips H, Ryan AM, Reichardt LF, Hynes M, Davies A, Rosenthal A. 1998. GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron 21:53-62.
10. Carpenter MK, Inokuma MS, Denham J, Mujtaba T, Chiu CP, Rao MS. 2001. Enrichment of neurons and neural precursors from human embryonic stem cells. Exp Neurol 172:383-397.
11. Carvey PM, Ling ZD, Sortwell CE, Pitzer MR, McGuire SO, Storch A, Collier TJ. 2001. A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease. Exp Neurol 171:98-108.
12. Chiba S, Kurokawa MS, Yoshikawa H, Ikeda R, Takeno M, Tadokoro M, Sekino H, Hashimoto T, Suzuki N. 2005. Noggin and basic FGF were implicated in forebrain fate and caudal fate, respectively, of the neural tube-like structures emerging in mouse ES cell culture. Exp Brain Res Hirnforschung 163:86-99.
13. Cho MS, Lee YE, Kim JY, Chung S, Cho YH, Kim DS, Kang SM, Lee H, Kim MH, Kim JH, Leem JW, Oh SK, Choi YM, Hwang DY, Chang JW, Kim DW. 2008. Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A 105:3392-3397.
14. Dhara SK, Stice SL. 2008. Neural differentiation of human embryonic stem cells. J Cell Biochem 105:633-640.
15. Dhara SK, Gerwe BA, Majumder A, Dodla MC, Boyd NL, Machacek DW, Hasneen K, Stice SL. 2009. Genetic manipulation of neural progenitors derived from human embryonic stem cells. Tissue Engineering (in press).
16. Di Nardo AA, Nedelec S, Trembleau A, Volovitch M, Prochiantz A, Montesinos ML. 2007. Dendritic localization and activity-dependent translation of Engrailed1 transcription factor. Mol Cell Neurosci 35:230-236.
17. Durbec P, Marcos-Gutierrez CV, Kilkenny C, Grigoriou M, Wartio-waara K, Suvanto P, Smith D, Ponder B, Costantini F, Saarma M, et al. 1996. GDNF signalling through the Ret receptor tyrosine kinase. Nature 381:789-793.
18. Dziennis S, Habecker BA. 2003. Cytokine suppression of dopamine-beta-hydroxylase by extracellular signal-regulated kinase-dependent and -independent pathways. J Biol Chem 278:15897-15904.
19. Elkabetz Y, Studer L. 2008. Human ESC-derived neural rosettes and neural stem cell progression. Cold Spring Harbor Symp Quant Biol 73:377-387.
20. Elkabetz Y, Panagiotakos G, Al Shamy G, Socci ND, Tabar V, Studer L. 2008. Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage. Genes Dev 22:152-165.
21. Erceg S, Lainez S, Ronaghi M, Stojkovic P, Perez-Arago MA, Moreno-Manzano V, Moreno-Palanques R, Planells-Cases R, Stojkovic M. 2008. Differentiation of human embryonic stem cells to regional specific neural precursors in chemically defined medium conditions. PLoS One 3:e2122.
22. Fasano CA, Studer L. 2009. Too much Sonic, too few neurons. Nat Neurosci 12:107-108.
23. Hedlund E, Pruszak J, Lardaro T, Ludwig W, Vinuela A, Kim KS, Isacson O. 2008. Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease. Stem Cells 26:1526-1536.
24. Hoffer BJ, Hoffman A, Bowenkamp K, Huettl P, Hudson J, Martin D, Lin LF, Gerhardt GA. 1994. Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci Lett 182:107-111.
25. Hudson J, Granholm AC, Gerhardt GA, Henry MA, Hoffman A, Biddle P, Leela NS, Mackerlova L, Lile JD, Collins F, et al. 1995. Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res Bull 36:425-432.
26. Hynes M, Rosenthal A. 1999. Specification of dopaminergic and serotonergic neurons in the vertebrate CNS. Curr Opin Neurobiol 9:26-36.
27. Hynes M, Porter JA, Chiang C, Chang D, Tessier-Lavigne M, Beachy PA, Rosenthal A. 1995. Induction of midbrain dopaminergic neurons by Sonic hedgehog. Neuron 15:35-44.
28. Johansson M, Friedemann M, Hoffer B, Stromberg I. 1995. Effects of glial cell line-derived neurotrophic factor on developing and mature ventral mesencephalic grafts in oculo. Exp Neurol 134:25-34.
29. Kim TS, Misumi S, Jung CG, Masuda T, Isobe Y, Furuyama F, Nishino H, Hida H. 2008. Increase in dopaminergic neurons from mouse embryonic stem cell-derived neural progenitor/stem cells is mediated by hypoxia inducible factor-1alpha. J Neurosci Res 86:2353-2362.
30. Li L, Wu W, Lin LF, Lei M, Oppenheim RW, Houenou LJ. 1995. Rescue of adult mouse motoneurons from injury-induced cell death by glial cell line-derived neurotrophic factor. Proc Natl Acad Sci U S A 92:9771-9775.
31. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F. 1993. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130-1132.
32. Liu J, Zang D. 2009. Response of neural precursor cells in the brain of Parkinson's disease mouse model after LIF administration. Neurol Res 31:681-686.
33. Messmer K, Remington MP, Skidmore F, Fishman PS. 2007. Induction of tyrosine hydroxylase expression by the transcription factor Pitx3. Int J Dev Neurosci 25:29-37.
34. Mijatovic J, Piltonen M, Alberton P, Mannisto PT, Saarma M, Piepponen TP. 2009. Constitutive Ret signaling is protective for dopaminergic cell bodies but not for axonal terminals. Neurobiol Aging (in press).
35. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. 1998. Dopamine receptors: from structure to function. Physiol Rev 78:189-225.
36. Pankratz MT, Li XJ, Lavaute TM, Lyons EA, Chen X, Zhang SC. 2007. Directed neural differentiation of human embryonic stem cells via an obligated primitive anterior stage. Stem Cells 25:1511-1520.
37. Paratcha G, Ledda F, Baars L, Coulpier M, Besset V, Anders J, Scott R, Ibanez CF. 2001. Released GFRalpha1 potentiates downstream signaling, neuronal survival, and differentiation via a novel mechanism of recruitment of c-Ret to lipid rafts. Neuron 29:171-184.
38. Perrier AL, Tabar V, Barberi T, Rubio ME, Bruses J, Topf N, Harrison NL, Studer L. 2004. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A 101:12543- 12548.
39. Piltonen M, Bespalov MM, Ervasti D, Matilainen T, Sidorova YA, Rauvala H, Saarma M, Mannisto PT. 2009. Heparin-binding determinants of GDNF reduce its tissue distribution but are beneficial for the protection of nigral dopaminergic neurons. Exp Neurol 219:499-506.
40. Rao SS, Hofmann LA, Shakil A. 2006. Parkinson's disease: diagnosis and treatment. Am Fam Physician 74:2046-2054.
41. Rosenblad C, Martinez-Serrano A, Bjorklund A. 1998. Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson's disease. Neuroscience 82:129-137.
42. Roy NS, Cleren C, Singh SK, Yang L, Beal MF, Goldman SA. 2006. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med 12:1259-1268.
43. Sauer H, Rosenblad C, Bjorklund A. 1995. Glial cell line-derived neuro-trophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc Natl Acad Sci U S A 92:8935-8939.
44. Shin S, Dalton S, Stice SL. 2005. Human motor neuron differentiation from human embryonic stem cells. Stem Cells Dev 14:266-269.
45. Shin S, Mitalipova M, Noggle S, Tibbitts D, Venable A, Rao R, Stice SL. 2006. Long-term proliferation of human embryonic stem cell-derived neuroepithelial cells using defined adherent culture conditions. Stem Cells 24:125-138.
46. Smidt MP, Burbach JP. 2007. How to make a mesodiencephalic dopaminergic neuron. Nat Rev Neurosci 8:21-32.
47. Storch A, Paul G, Csete M, Boehm BO, Carvey PM, Kupsch A, Schwarz J. 2001. Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells. Exp Neurol 170:317-325.
48. Stromberg I, Bjorklund L, Johansson M, Tomac A, Collins F, Olson L, Hoffer B, Humpel C. 1993. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp Neurol 124:401-412.
49. Tansey MG, Baloh RH, Milbrandt J, Johnson EM Jr. 2000. GFRalphamediated localization of RET to lipid rafts is required for effective downstream signaling, differentiation, and neuronal survival. Neuron 25:611-623.
50. Tavakoli T, Xu X, Derby E, Serebryakova Y, Reid Y, Rao MS, Mattson MP, Ma W. 2009. Self-renewal and differentiation capabilities are variable between human embryonic stem cell lines I3, I6 and BG01V. BMC Cell Biol 10:44.
51. Tomac A, Lindqvist E, Lin LF, Ogren SO, Young D, Hoffer BJ, Olson L. 1995. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373:335-339.
52. Weintraub D, Comella CL, Horn S. 2008. Parkinson's disease-Part 1: pathophysiology, symptoms, burden, diagnosis, and assessment. Am J Managed Care 14(Suppl):S40-S48.
53. Wernig M, Zhao JP, Pruszak J, Hedlund E, Fu D, Soldner F, Broccoli V, Constantine-Paton M, Isacson O, Jaenisch R. 2008. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A 105:5856-5861.
54. Yan Y, Yang D, Zarnowska ED, Du Z, Werbel B, Valliere C, Pearce RA, Thomson JA, Zhang SC. 2005. Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells 23:781-790.
55. Zeng X, Cai J, Chen J, Luo Y, You ZB, Fotter E, Wang Y, Harvey B, Miura T, Backman C, Chen GJ, Rao MS, Freed WJ. 2004. Dopaminergic differentiation of human embryonic stem cells. Stem Cells 22:925-940.